The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome

Carlioglu, Ayse; Kaygusuz, Ikbal; Karakurt, Feridun; Gumus, Ilknur; Uysal, Aysel; KASAPOĞLU, BENAN; Armutcu, Ferah; Uysal, Sema; Keskin, Esra; Koca, Cemile

doi:10.1007/s00404-014-3275-8

The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome

Carlioglu A., Kaygusuz I., Karakurt F., Gumus I. I. , Uysal A., KASAPOĞLU B. , ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.290, no.5, pp.929-935, 2014 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 290 Issue: 5
Publication Date: 2014
Doi Number: 10.1007/s00404-014-3275-8
Title of Journal : ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Page Numbers: pp.929-935
Keywords: Polycystic ovary syndrome, Platelet activating factor acetyl hydrolyze, Oxidized LDL, Paraoxonase1, Paraoxonase1 phenotypes, Arylesterase, CORONARY-ARTERY-DISEASE, ACETYLHYDROLASE PAF-AH, INTIMA-MEDIA THICKNESS, RISK-FACTOR, CARDIOVASCULAR-DISEASE, INSULIN-RESISTANCE, HEART-DISEASE, CHRONIC INFLAMMATION, PHOSPHOLIPASE A(2), OXIDATIVE STRESS

Abstract

Purpose To evaluate the platelet activating factor acetyl hydrolyze (PAF-AH), oxidized low-density lipoprotein (ox-LDL), paraoxonase 1 (PON1), arylesterase (ARE) levels and the effects of metformin and Diane-35 (ethinyl oestradiol + cyproterone acetate) therapies on these parameters and to determine the PON1 polymorphisms among PCOS patients.